CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Top Cited Papers
- 1 July 2009
- Vol. 138 (2), 271-285
- https://doi.org/10.1016/j.cell.2009.05.046
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral TissuesCell, 2007
- Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47nullcellsProceedings of the National Academy of Sciences, 2007
- Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytesBiochemical and Biophysical Research Communications, 2007
- Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organsThe EMBO Journal, 2006
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005
- Promotion of Neurite and Filopodium Formation by CD47: Roles of Integrins, Rac, and Cdc42Molecular Biology of the Cell, 2004
- Circulation and Chemotaxis of Fetal Hematopoietic Stem CellsPLoS Biology, 2004
- Robust and Efficient Regulation of Transgene Expression in Vivo by Improved Tetracycline-Dependent Lentiviral VectorsMolecular Therapy, 2002
- Integrin-associated protein (CD47) and its ligandsTrends in Cell Biology, 2001